Mount Lucas Management LP decreased its position in MetLife, Inc. (NYSE:MET - Free Report) by 59.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,642 shares of the financial services provider's stock after selling 18,839 shares during the period. Mount Lucas Management LP's holdings in MetLife were worth $1,043,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in MET. Orion Portfolio Solutions LLC raised its holdings in shares of MetLife by 1.3% in the 1st quarter. Orion Portfolio Solutions LLC now owns 29,942 shares of the financial services provider's stock valued at $2,219,000 after buying an additional 397 shares during the period. First Foundation Advisors acquired a new position in shares of MetLife in the first quarter valued at approximately $72,000. Vanguard Group Inc. increased its stake in MetLife by 3.4% during the 1st quarter. Vanguard Group Inc. now owns 59,622,348 shares of the financial services provider's stock worth $4,418,612,000 after buying an additional 1,974,268 shares during the period. Acadian Asset Management LLC acquired a new stake in MetLife during the 1st quarter worth approximately $1,053,000. Finally, Edgestream Partners L.P. boosted its position in MetLife by 31.7% in the 1st quarter. Edgestream Partners L.P. now owns 7,002 shares of the financial services provider's stock valued at $519,000 after buying an additional 1,684 shares during the period. Hedge funds and other institutional investors own 89.81% of the company's stock.
MetLife Stock Performance
Shares of MET traded up $0.73 during mid-day trading on Friday, hitting $83.33. 4,393,104 shares of the company's stock were exchanged, compared to its average volume of 3,326,607. The business's 50 day moving average is $81.60 and its two-hundred day moving average is $75.59. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $57.70 billion, a P/E ratio of 16.80, a P/E/G ratio of 0.76 and a beta of 1.05. MetLife, Inc. has a fifty-two week low of $61.61 and a fifty-two week high of $86.94.
MetLife Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be given a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.62%. MetLife's payout ratio is 43.95%.
Analysts Set New Price Targets
Several brokerages have recently issued reports on MET. TD Cowen assumed coverage on MetLife in a research note on Wednesday, October 9th. They issued a "buy" rating and a $97.00 price objective on the stock. Citigroup boosted their price objective on MetLife from $83.00 to $89.00 and gave the stock a "buy" rating in a research report on Tuesday, July 23rd. Wells Fargo & Company raised their target price on shares of MetLife from $92.00 to $93.00 and gave the company an "overweight" rating in a report on Tuesday, November 5th. StockNews.com upgraded shares of MetLife from a "hold" rating to a "buy" rating in a report on Tuesday, November 12th. Finally, Piper Sandler raised their price objective on shares of MetLife from $85.00 to $92.00 and gave the company an "overweight" rating in a report on Wednesday, October 2nd. Fourteen equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $88.46.
View Our Latest Stock Analysis on MET
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.